The Optimal One-Month Dosing of Lemborexant for Moderate Obstructive Sleep Apnea (OSA) Patients With Low Arousal Threshold

NCT07683442 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

NOT_YET_RECRUITING

Status

36

Enrollment

OTHER

Sponsor class

Conditions

OSA - Obstructive Sleep Apnea

Interventions

DRUG: Lemborexant 5 MG [Dayvigo] Period 1
DRUG: Placebo Period 1
DRUG: Lemborexant 5 MG [Dayvigo] Period 2
DRUG: Placebo Period 2
DRUG: Lemborexant 5 MG [Dayvigo] Period 3
DRUG: Placebo Period 3
DRUG: Lemborexant 10 MG [Dayvigo] Period 1
DRUG: Lemborexant 10 MG [Dayvigo] Period 2
DRUG: Lemborexant 10 MG [Dayvigo] Period 3

Sponsor

Chulalongkorn University